FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

CRN Praises Court Decision in Fish Oil Case

[ Price : $8.95]

The Council for Responsible Nutrition praises the Supreme Courts refusal to hear an Amrin appeal of a fish oil dietary supplement ...

Alert on Recalled Products from Basic Reset/Biogenyx

[ Price : $8.95]

FDA says 25 unapproved drug, dietary supplement and medical device product lines distributed by Basic Reset and Biogenyx, have bee...

Waxman-Hatch at Risk: Analysis

[ Price : $8.95]

Attorney Kurt Karst says Congress is considering drug pricing legislation that is opposed by the Association for Accessible Medici...

BIO Blasts USMCA Provision

[ Price : $8.95]

BIO president Jim Greenwood says the administration and House Democrats have surrendered a powerful tool to protect American biote...

Senators Want Action on Hearing Aid Regs

[ Price : $8.95]

Sens. Grassley and Warren ask FDA when draft OTC hearing aid regulations will be published

Verax Asks FDA Not to Take Arbitrary Action

[ Price : $8.95]

Verax Biomedical calls on FDA not to take actions that would be considered arbitrary and capricious if unsupported by additional s...

Regenerative Therapies Outcome Measures Needed: Report

[ Price : $8.95]

The Alliance for Cell Therapy Now calls on FDA and other agencies to act to measure outcomes related to regenerative cell therapie...

Vabomeres Regulatory Review Period Determined

[ Price : $8.95]

Federal Register notice: FDA determines for patent extension purposes the regulatory review period for Rempex Pharmaceuticals Vabo...

Info Collection on Minor Use/Species Drugs

[ Price : $8.95]

Federal Register notice: FDA sends to OMB an information collection extension for Reporting Associated With Designated New Animal ...

CGMP Violations Found in Teligent Inspection

[ Price : $8.95]

FDA warns Teligent Pharma about CGMP and Field Alert Report violations in its manufacturing of finished pharmaceuticals.